First evidence drug-resistant malaria mutations gaining foothold in Africa, study suggests – The Independent

Drug-resistant mutations in a malaria parasite may be gaining a foothold in Africa, according to data from a new study.
The research, which has been published in The Lancet Infectious Diseases journal, found for the first time that mutations in Plasmodium falciparum parasites in Rwanda were associated with a reduction in the effectiveness of common therapies for children with malaria.
Artemisinin-based combination therapies (ACTs) are currently the most effective and widely-used treatments for malaria…

Click here to view the original article.